» Articles » PMID: 20122022

Geriatric Assessment in Oncology Practice

Overview
Specialty Geriatrics
Date 2010 Feb 4
PMID 20122022
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

There is no standard tool for assessing the "functional age" of an older adult with cancer, although it is widely recognized that chronological age does not capture the heterogeneous physiological and functional status of older adults. Integrating a "geriatric assessment" into oncology research and clinical practice would help fill this void. Geriatric assessment covers factors that predict morbidity and mortality in older adults, including functional status, comorbidity, cognition, psychological state, nutritional status, and social support. This assessment provides a broader overall understanding of individual characteristics that affect life expectancy. In addition, this assessment identifies areas of vulnerability in older adults for which further evaluation or intervention is indicated. This article will address the utility of a geriatric assessment in oncology practice, review data that attest to the benefits of the assessment, and issue a call for further research into how this assessment can be integrated into oncology care. Doing so will help develop targeted interventions and optimize cancer outcomes in this rapidly growing population.

Citing Articles

Social Justice and Equity: Why Older Adults With Cancer Belong-A Life Course Perspective.

Yilmaz S, Sanapala C, Schiaffino M, Schumacher J, Wallington S, McKoy J Am Soc Clin Oncol Educ Book. 2022; 42:1-13.

PMID: 35649203 PMC: 11070065. DOI: 10.1200/EDBK_349825.


Barriers to Accessing, Commencing and Completing Cancer Treatment Among Geriatric Patients in Rural Australia: A Qualitative Perspective.

George M, Smith A, Ranmuthugula G, Sabesan S Int J Gen Med. 2022; 15:1583-1594.

PMID: 35210830 PMC: 8859537. DOI: 10.2147/IJGM.S338128.


The missing voice in multidisciplinary tumor boards.

Rocque G, Wheeler S, Williams G J Geriatr Oncol. 2021; 12(8):1157-1158.

PMID: 33722503 PMC: 8435048. DOI: 10.1016/j.jgo.2021.03.004.


Eligibility of real-world patients with metastatic breast cancer for clinical trials.

Batra A, Kong S, Cheung W Breast. 2020; 54:171-178.

PMID: 33120082 PMC: 7586241. DOI: 10.1016/j.breast.2020.10.005.


Personalised treatment for older adults with cancer: The role of frailty assessment.

ODonovan A, Leech M Tech Innov Patient Support Radiat Oncol. 2020; 16:30-38.

PMID: 33102819 PMC: 7568178. DOI: 10.1016/j.tipsro.2020.09.001.


References
1.
Overcash J, Beckstead J, Moody L, Extermann M, Cobb S . The abbreviated comprehensive geriatric assessment (aCGA) for use in the older cancer patient as a prescreen: scoring and interpretation. Crit Rev Oncol Hematol. 2006; 59(3):205-10. DOI: 10.1016/j.critrevonc.2006.04.003. View

2.
Hutchins L, Unger J, Crowley J, COLTMAN Jr C, Albain K . Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med. 1999; 341(27):2061-7. DOI: 10.1056/NEJM199912303412706. View

3.
Audisio R, Ramesh H, Longo W, Zbar A, Pope D . Preoperative assessment of surgical risk in oncogeriatric patients. Oncologist. 2005; 10(4):262-8. DOI: 10.1634/theoncologist.10-4-262. View

4.
Hurria A, Gupta S, Zauderer M, Zuckerman E, Cohen H, Muss H . Developing a cancer-specific geriatric assessment: a feasibility study. Cancer. 2005; 104(9):1998-2005. DOI: 10.1002/cncr.21422. View

5.
Maione P, Perrone F, Gallo C, Manzione L, Piantedosi F, Barbera S . Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the.... J Clin Oncol. 2005; 23(28):6865-72. DOI: 10.1200/JCO.2005.02.527. View